5.43 Patterns of Nodal Response and Lymphocytosis in Patients with Previously Treated CLL Receiving the Selective Phosphatidylinositol 3-Kinase-Delta (PI3Kδ) Inhibitor, CAL-101 (GS-1101) Alone or in Combination with Rituximab (R) or Bendamustine (B)

Saved in:
Bibliographic Details
Published inClinical lymphoma, myeloma and leukemia Vol. 11; pp. S272 - S274
Main Authors Brown, Jennifer R, Jahn, Thomas M, Furman, Richard R, Leonard, John P, Spurgeon, Stephen E, Byrd, John C, Benson, Don M, Coutre, Steven E, Wagner-Johnston, Nina D, Flinn, Ian W, Kahl, Brad S, Schreeder, Marshall T, de Vos, Sven, Holes, Leanne M, Peterman, Harriet (Sissy), Johnson, Dave M, Miller, Langdon L
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.10.2011
Subjects
Hematology, Oncology and Palliative Medicine
Online AccessGet full text

Cover

More Information
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2011.09.197